Moreover, transgenic mice expressing HIV-1 Tat develop larger and more severe KS-like lesions compared with mice transgenic for an RGD-deleted Tat [123], further emphasizing the role of the interaction of eTat with RGD-binding integrins in this AIDS-associated tumor. The gene discussed is TAT; the disease is Kaposi's sarcoma.